| Size | Price | Stock | Qty |
|---|---|---|---|
| 50mg |
|
||
| 100mg |
|
||
| 250mg |
|
||
| 500mg | |||
| Other Sizes |
| Targets |
D-Citronellol does not have a specific defined pharmacological target but is known to modulate mast cell function. It inhibits degranulation of cultured mast cells. As a monoterpene alcohol, it may interact with multiple cellular targets, including membrane receptors and ion channels, contributing to its biological activities.
|
|---|---|
| ln Vitro |
0.5 mM (R)-citronellol (D-citronellol) prevents 21.3% of cultured mast cell (CMC) degranulation[2].
D-Citronellol (0.5 mM) inhibits degranulation of cultured mast cells by 21.3%. The compound has been studied for its effects on mast cell function and potential anti-allergic properties. It is also used in decorative cosmetics, lotion products, and non-cosmetic applications. In vitro studies show that D-Citronellol does not affect caffeine bitterness perception. |
| ln Vivo |
In vivo studies on D-Citronellol are limited. The compound is a constituent of black cumin (Nigella sativa) seeds and is prevalent in essential oils of various aromatic plant species. As a natural monoterpene, it has been traditionally used in aromatherapy and cosmetic applications. Further in vivo pharmacological studies are needed to fully characterize its biological effects.
|
| Enzyme Assay |
In vitro enzyme/receptor binding assays for D-Citronellol are not well established. As a monoterpenoid, it may interact with olfactory receptors and other membrane proteins. Binding studies typically involve assessing the compound's ability to modulate mast cell degranulation or other cellular responses rather than direct receptor binding. Standard radioligand binding assays could be adapted to study potential receptor interactions.
|
| Cell Assay |
In vitro cell-based assays for D-Citronellol typically utilize mast cell cultures. Cultured mast cells are treated with D-Citronellol at concentrations such as 0.5 mM, and degranulation is measured by assessing the release of β-hexosaminidase or histamine following stimulation with IgE-antigen complexes or other secretagogues. Cell viability is assessed to ensure compound concentrations are not cytotoxic.
|
| Animal Protocol |
D-Citronellol is a natural product, and in vivo animal studies are limited. As a component of essential oils, it has been studied in the context of aromatherapy and topical applications. For pharmacological evaluation, animal models of allergic inflammation could potentially be used to assess the anti-allergic effects of D-Citronellol. However, comprehensive in vivo pharmacokinetic and pharmacodynamic studies are lacking.
|
| ADME/Pharmacokinetics |
As a small lipophilic molecule, D-Citronellol (MW 156.27, logP ~3.5) is expected to have good oral absorption and tissue penetration. It is commonly used in topical cosmetic formulations, indicating favorable skin permeability. The compound has a boiling point of 224.5°C and density of 0.857 g/mL at 25°C. D-Citronellol is volatile and should be stored in tightly sealed containers away from light and heat.
|
| Toxicity/Toxicokinetics |
D-Citronellol is generally recognized as safe for use in cosmetics and food flavoring. It is a natural monoterpene with low toxicity. At the tested concentration of 0.5 mM, it inhibits mast cell degranulation without significant cytotoxicity. As with all essential oil components, it may cause skin irritation in sensitive individuals at high concentrations.
|
| References |
|
| Additional Infomation |
(R)-(+)-Citronellol is an octyl-6-ene derivative with a hydroxyl group substituted at the 1-position and methyl groups substituted at the 3- and 7-positions (3R-enantiomer). It is the enantiomer of (S)-(-)-Citronellol. D-Citronellol has been reported in pomegranate (Punica granatum), capsicum annuum, and other organisms with relevant data. See also: β-Citronellol, (R)-; Geraniol (ingredient)... See more...
D-Citronellol is a naturally occurring monoterpenoid alcohol found in essential oils of various plants including rose, geranium, and lemon. It is the (R)-enantiomer of citronellol and is also known as (R)-(+)-β-citronellol. The compound has applications in the fragrance and flavor industries, as well as in cosmetic formulations. It is also an endogenous metabolite identified in Cannabis. This compound is not a drug but a natural product with potential biological activities. |
| Molecular Formula |
C10H20O
|
|---|---|
| Molecular Weight |
156.27
|
| Exact Mass |
156.151
|
| CAS # |
1117-61-9
|
| Related CAS # |
Citronellol;106-22-9
|
| PubChem CID |
101977
|
| Appearance |
Colorless to light yellow liquid
|
| Density |
0.857 g/mL at 25ºC(lit.)
|
| Boiling Point |
224.5ºC at 760 mmHg
|
| Flash Point |
98.3ºC
|
| Vapour Pressure |
~0.02 mm Hg ( 25 °C)
|
| Index of Refraction |
n20/D 1.456(lit.)
|
| LogP |
2.751
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
1
|
| Rotatable Bond Count |
5
|
| Heavy Atom Count |
11
|
| Complexity |
112
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
OCC[C@@H](CC/C=C(/C)\C)C
|
| InChi Key |
QMVPMAAFGQKVCJ-SNVBAGLBSA-N
|
| InChi Code |
InChI=1S/C10H20O/c1-9(2)5-4-6-10(3)7-8-11/h5,10-11H,4,6-8H2,1-3H3/t10-/m1/s1
|
| Chemical Name |
(3R)-3,7-dimethyloct-6-en-1-ol
|
| Synonyms |
AI3-00204; AI3-00204; D-Citronellol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ~100 mg/mL (~639.92 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (16.00 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (16.00 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. View More
Solubility in Formulation 3: ≥ 2.5 mg/mL (16.00 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.3992 mL | 31.9959 mL | 63.9918 mL | |
| 5 mM | 1.2798 mL | 6.3992 mL | 12.7984 mL | |
| 10 mM | 0.6399 mL | 3.1996 mL | 6.3992 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
